 Dyslipidemias
"Dyslipidemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Descriptor ID |
D050171
|
| MeSH Number(s) |
C18.452.584.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dyslipidemias".
Below are MeSH descriptors whose meaning is more specific than "Dyslipidemias".
This graph shows the total number of publications written about "Dyslipidemias" by people in this website by year, and whether "Dyslipidemias" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 1 | 2 | | 2006 | 3 | 1 | 4 | | 2007 | 5 | 2 | 7 | | 2008 | 4 | 2 | 6 | | 2009 | 2 | 1 | 3 | | 2010 | 4 | 1 | 5 | | 2011 | 2 | 2 | 4 | | 2012 | 2 | 3 | 5 | | 2013 | 4 | 3 | 7 | | 2014 | 4 | 2 | 6 | | 2015 | 4 | 3 | 7 | | 2016 | 3 | 4 | 7 | | 2017 | 9 | 0 | 9 | | 2018 | 5 | 4 | 9 | | 2019 | 9 | 3 | 12 | | 2020 | 4 | 1 | 5 | | 2021 | 6 | 1 | 7 | | 2022 | 3 | 1 | 4 | | 2023 | 3 | 0 | 3 | | 2024 | 6 | 3 | 9 | | 2025 | 7 | 0 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Dyslipidemias" by people in Profiles.
-
Myerson M, Warden BA, Saseen JJ, Paparodis R. Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction. J Am Heart Assoc. 2025 Oct 21; 14(20):e044134.
-
Reijnders E, Bossuyt PM, Jukema JW, Ruhaak LR, Romijn FPHTM, Szarek M, Trompet S, Bhatt DL, Bittner VA, Diaz R, Fazio S, Stevanovic I, Goodman SG, Harrington RA, White HD, Steg PG, Schwartz GG, Cobbaert CM. Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy. Arterioscler Thromb Vasc Biol. 2025 Nov; 45(11):2111-2123.
-
Walker M, Riggs KA, Rohatgi A, Beckman J, Addo T, Girotra S, Bonaca MP, Armstrong E, Kumbhani DJ. Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions. J Am Heart Assoc. 2025 Oct 07; 14(19):e039734.
-
Wu X, Wilke M, Batara J, Proctor S, Cree M, Ghosh M, Raggi P, Windram J, Becher H, Vine D. Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study. Front Endocrinol (Lausanne). 2025; 16:1520922.
-
Du W, Zhou W, Guan F, Huang F, Zhang X, Zhang J, Jia X, Su C, Ouyang Y, Wang H, Zhang B. [Development and validation of a prediction model for dyslipidemia in adults based on gut microbiota features of 4 provinces]. Wei Sheng Yan Jiu. 2025 Sep; 54(5):738-743.
-
Aggarwal R, Bhatt DL, Steg PG, Miller M, Brinton EA, Dunbar RL, Ketchum SB, Tardif JC, Martens FMAC, Ballantyne CM, Szarek M, Mason RP. Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 04; 14(5):e038656.
-
Patel SB, Wyne KL, Afreen S, Belalcazar LM, Bird MD, Coles S, Marrs JC, Peng CC, Pulipati VP, Sultan S, Zilbermint M. American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia. Endocr Pract. 2025 Feb; 31(2):236-262.
-
Wu X, Guan F, Su C, Zhang J, Jia X, Wei Y, Huang F, Li L, Bai J, Ouyang Y, Zhang X, Wang H, He Y, Du W. [Status and epidemic trends of major chronic metabolic diseases among adult residents in 10 provinces (autonomous regions) of China in 2009-2023]. Wei Sheng Yan Jiu. 2024 Nov; 53(6):880-913.
-
Guan F, He Y, Su C, Wei Y, Zhang X, Huang F, Ouyang Y, Li L, Bai J, Jia X, Zhang J, Du W, Wang H. [Distribution and epidemic trends of chronic multimorbidity among adult residents in 10 provinces (autonomous regions)of China in 2009-2023]. Wei Sheng Yan Jiu. 2024 Nov; 53(6):887-892.
-
Ngatu NR, Hossain A, Maruo N, Akumwami S, Rahman AM, Eitoku M, Kanda K, Nishiyama A, Suganuma N, Hirao T. NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo. Int J Mol Sci. 2024 Oct 09; 25(19).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|